“Biophytis Brings the Bio Heat to BIOMED FORUM: A Conference You Won’t Want to Miss!”

Paris, France and Cambridge, Massachusetts–(Newsfile Corp. – January 27, 2025) – Biophytis SA (FP: ALBPS) Biophytis SA to Participate in Biomed Forum in Paris Biophytis SA, a clinical-stage biotechnology company specializing in the development of treatments for age-related diseases, has announced its participation in the Biomed Forum organized by All Invest Securities on February 4,…

Read More

Discover the 7 Unstoppable Growth Stocks with the Potential to Transform $1,000 into $7 Million: A Heartfelt and Insightful Journey to Financial Success

The Power of Anticipating and Monetizing Trends: A Game-Changer for Businesses and Investors In today’s ever-evolving business landscape, the ability to accurately predict and monetize emerging trends is becoming increasingly crucial for companies and management teams. This skill set not only sets them apart from their competitors but also opens up new opportunities for substantial…

Read More

“Unleashing the Power of Perpetua: Rosen Investor Counsel Urges Business Professionals to Take Notice of This Resourceful Corporation”

Rosen Law Firm Investigates Potential Securities Claims Against Perpetua Resources Corp. What You Need to Know Rosen Law Firm, a global investor rights law firm, has announced an investigation of potential securities claims on behalf of shareholders of Perpetua Resources Corp. (NASDAQ:PPTA). The investigation stems from allegations that Perpetua Resources may have issued materially misleading…

Read More

Innovative Biologic NurExone Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

NurExone Biologic Inc. Receives Orphan Medicinal Product Designation for ExoPTEN Therapy TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) NurExone Biologic Inc. has recently announced that the European Medicines Agency has granted Orphan Medicinal Product Designation for the company’s ExoPTEN therapy. This is a significant milestone for NurExone, a biopharmaceutical company focused on developing…

Read More

Calling All Ampio Pharmaceuticals Inc. Investors: Don’t Miss Out on Legal Protection! Rosen Law Firm Urges You to Act Before the Securities Class Action Deadline

What You Need to Know About the Ampio Pharmaceuticals Class Action Lawsuit A Brief Overview In a recent announcement, the Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) securities. The lawsuit covers a period between December 29,…

Read More

US Government Takes Legal Action Against Apple for Allegedly Manipulating Regulations to Target Crypto Apps

DOJ Sues Apple for Monopoly Attacking Apple’s App Store Policies The United States Department of Justice (DOJ) has taken a significant step in the ongoing battle against tech giant Apple by filing a lawsuit that alleges antitrust violations related to the company’s App Store policies. This legal action comes as a result of concerns that…

Read More